Monday , August 2 2021

The mortality of melanoma grows in men, the study says



There is evidence that men are unlikely to protect themselves from the sun, "said the researcher

The level of malignant malignancies in malignant cells has risen globally, while in some countries the rates are flat or lower for women, according to a study from NCRI's 2018 Cancer Conference.
Melanoma is the most deadly skin cancer, although it is not the most common. It comes from melanocytes, cells that produce melanin. It is only 5% of skin cancer cases but it has a high capacity to produce and distribute metastases to other organs such as the liver, lungs, and brain. It almost always occurs when the ink is damaged, or in black and another with many different colors.
Scientists are researching the World Health Organization's WHO-funded deaths worldwide focusing on 33 countries with reliable data. They found that the number of melanoma males in men increased in all countries except for the Czech Republic.
They say that more research is needed to understand the causes of this trend, but on the other hand, more public health efforts are needed for people to increase the awareness of the disease.
Researchers are investigating the deaths of age groups in 33 countries in 1985 to 2015. These rates take into account some of the aging populations and other young populations. They eradicated malignant melanoma, the most dangerous skin cancer cases, and compared men's and women's prices by analyzing trends over time.
In all countries prices were higher for men than for women. The highest mortality rates were in 2013-2015 in Australia (5.72 / 100.000 men and 2.53 / 100.000 women) and Slovenia (3.86 in males and 2.58 in females). In Japan (0.24 in men and 0.18 in women).
The Czech Republic was the only country where researchers found a decrease in the mortality of melanoma among men, with an annual percentage reduction of 0.7 percent in 1985-2005. Israel and the Czech Republic had the highest rates of mortality in women: 23.4% and 15.5% respectively.
Paper was presented by Dr. Royal Dorothy Yang, Royal Free London NHS Foundation Trust. According to her, the main risk factor for melanoma is exposure to ultraviolet radiation either by exposure to sunlight or tanning.
"There is evidence that men are unlikely to protect the sun or recognize and prevent melanoma campaigns, and are also pursuing work by looking for biological factors based on the difference in mortality between men and women."
He added: "The incidence of melanoma has increased in recent decades despite public health efforts to increase awareness and promote intelligent behavior of melanoma. However, some recent reports have shown signs of severity stabilization and a decline in melanoma deaths, for example in Australia and Northern Europe.

Researchers develop research to detect the disease

A group of Australian researchers announced a new blood test to detect melanoma at an early stage, a worldwide finding that could save many lives.
The test can help doctors detect melanoma, highly aggressive skin cancer, before it spreads elsewhere in the body, according to researchers at the University of Cowan, published by the Oncotarget magazine.
The study involved 105 melanoma patients and 104 healthy people. The method used allowed early diagnosis of melanoma in 79% of cases according to the investigators.
"This blood test is a very promising potential indicator because it can detect melanoma at its initial stage when it can still be treated," said leading researcher Pauline Zaenker in his statement.
"Patients with early melanoma have a five-year survival rate of 90-99 percent," Zaenker said.
Otherwise, the survival rate will drop to 50%.
At present, melanoma is detected by a clinical examination performed by a physician and assumed to be an injury to a biopsy.
"We reviewed a total of 1,627 different antibody types to identify the 10 antibody combinations that best demonstrated the presence of melanoma in confirmed patients compared to healthy volunteers," explained Zaenker.
The research team prepares a clinical trial lasting three years to verify the findings and have a physician available test.
One of the three cancer types is skin cancer according to the World Health Organization (WHO). Australia is the country with the most prevalent incidence of melanoma in the world.


Source link